Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.

Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res. 2007 Jun 15; 67(12):5821-30.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.